Functional Subtyping with BluePrint 80-gene profile identifies 2 distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity: implications for treatment from NBRST registry. Beitsch, Gittleman, Whitworth - J Clin Oncol. 2015 Oct.
Whitworth PW, Beitsch PD, Gittleman M et al. Functional subtyping with BluePrint 80-gene profile to identify distinct triple-positive subtypes with and without trastuzumab/chemosensitivity. J Clin Oncol. 2015 Oct. 33(28): 114.
Vivamus molestie gravida turpis
Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor. Beitsch, Gittleman et al - PLoS One. 2015 Nov.
Spector N, Beitsch P, Gittleman M et al. Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor. PLoS ONE. 2015 Nov 10(11): e0142845. doi: 10.1371/journal.pone.0142845.
Circulating tumor Cells in Patients with Breast Cancer Dormancy. Beitsch et al - Clinical Cancer Research. 2004 Dec.